Demonstrated efficacy |
Monitoring |
Safety and tolerability profile |
||
|
Explore MAVENCLAD’s efficacy. |
Discover MAVENCLAD’s monitoring. |
Learn about MAVENCLAD’s safety and |
Footnotes and References
Reference
- MAVENCLAD™ Product Monograph. EMD Serono. November 2017.
- Giovannoni G, et al. A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis. N Engl J Med 2010;362:416-26.